drugset / Trial / NCT03600831
Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell Carcinoma
Phase 2/3
Completed
434 enrolled
Huai'an First People's Hospital
Chinese People's Liberation Army No. 82 Hospital · collabThe Second People's Hospital of Huai'an · collablian shui county People's Hospital · collabxuyi People's Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of this study is to investigate the effect of postoperative concurrent chemoradiotherapy versus radiotherapy alone for patients with locally advanced esophageal squamous cell carcinoma.
Timeline
- Start
- 2018-08-20
- Primary completion
- 2022-05-30
- Completion
- 2023-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 25 mg/m2 | — |
| Subject | Docetaxel | Small molecule | 25 mg/m2 | — |